Matches in SemOpenAlex for { <https://semopenalex.org/work/W2011140517> ?p ?o ?g. }
Showing items 1 to 71 of
71
with 100 items per page.
- W2011140517 endingPage "406" @default.
- W2011140517 startingPage "401" @default.
- W2011140517 abstract "Today, many single-pill combinations (SPC) exist and are used as a promising choice in hypertension treatment. However, this trend made more of a challenge to analysts in Pharmaceutical Quality Control Laboratories. In this work, three sensitive and selective analytical methods were proposed for simultaneous determination of two anti-hypertension drugs; Oxprenolol (OXP) and Cyclopenthiazide (CYPZ) in bulk powder and in laboratory prepared tablets “LPTs”. Two of them were simple spectrophotometric methods (derivative and derivative ratio) and the third was HPLC-DAD method. For the spectrophotometric methods, the major problem encountered during analysis was attributed to the extensive spectral overlap and the challenging ratio of both drugs in their dosage form, CYPZ:OXP (0.2:100). The derivative (D) method was based on using the first derivative (1D) and second derivative (2D) spectra for the quantitative analysis of CYPZ at 335.5 nm and OXP at 280.5 nm, respectively. While for the derivative ratio method (1DR), OXP was determined at 285.5 nm and CYPZ at 335.5 nm. The HPLC method was based on the separation of both drugs on a C18 column with a mobile phase containing acetonitrile and 50 mM phosphate buffer of pH 3.5 (50:50). In order to quantify OXP and CYPZ accurately and maximize the assay sensitivity; the DAD was set at 224 nm. Optimization of chromatographic conditions was done at which OXP eluted at 4.34 min and CYPZ at 6.73 min with optimum sharpness and peak symmetry. The study of forced degradation of both drugs was done under various conditions including; hydrolysis (acid, alkaline and neutral), oxidation, dry heat and photo-decomposition. The proposed method could separate each drug peak from those of the different forced degradation product peaks and the purity of the drugs peaks was confirmed using the photo-diode array detector. The data obtained by spectrophotometric and HPLC methods were statistically comparable by ANOVA test. No significant difference was recorded between the mean percent levels determined by the proposed methods." @default.
- W2011140517 created "2016-06-24" @default.
- W2011140517 creator A5061260001 @default.
- W2011140517 creator A5087803359 @default.
- W2011140517 date "1987-01-01" @default.
- W2011140517 modified "2023-09-27" @default.
- W2011140517 title "Determination of cyclopenthiazide in plasma by high-performance liquid chromatography" @default.
- W2011140517 cites W2000818586 @default.
- W2011140517 cites W2009842426 @default.
- W2011140517 cites W2045517921 @default.
- W2011140517 cites W2057108736 @default.
- W2011140517 cites W2076251938 @default.
- W2011140517 doi "https://doi.org/10.1016/0378-4347(87)80425-5" @default.
- W2011140517 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/3429594" @default.
- W2011140517 hasPublicationYear "1987" @default.
- W2011140517 type Work @default.
- W2011140517 sameAs 2011140517 @default.
- W2011140517 citedByCount "3" @default.
- W2011140517 countsByYear W20111405172017 @default.
- W2011140517 crossrefType "journal-article" @default.
- W2011140517 hasAuthorship W2011140517A5061260001 @default.
- W2011140517 hasAuthorship W2011140517A5087803359 @default.
- W2011140517 hasConcept C106159729 @default.
- W2011140517 hasConcept C111771559 @default.
- W2011140517 hasConcept C126838900 @default.
- W2011140517 hasConcept C134306372 @default.
- W2011140517 hasConcept C162324750 @default.
- W2011140517 hasConcept C179998833 @default.
- W2011140517 hasConcept C185592680 @default.
- W2011140517 hasConcept C2776271928 @default.
- W2011140517 hasConcept C33257320 @default.
- W2011140517 hasConcept C33923547 @default.
- W2011140517 hasConcept C43617362 @default.
- W2011140517 hasConcept C71924100 @default.
- W2011140517 hasConcept C77281830 @default.
- W2011140517 hasConcept C84393581 @default.
- W2011140517 hasConceptScore W2011140517C106159729 @default.
- W2011140517 hasConceptScore W2011140517C111771559 @default.
- W2011140517 hasConceptScore W2011140517C126838900 @default.
- W2011140517 hasConceptScore W2011140517C134306372 @default.
- W2011140517 hasConceptScore W2011140517C162324750 @default.
- W2011140517 hasConceptScore W2011140517C179998833 @default.
- W2011140517 hasConceptScore W2011140517C185592680 @default.
- W2011140517 hasConceptScore W2011140517C2776271928 @default.
- W2011140517 hasConceptScore W2011140517C33257320 @default.
- W2011140517 hasConceptScore W2011140517C33923547 @default.
- W2011140517 hasConceptScore W2011140517C43617362 @default.
- W2011140517 hasConceptScore W2011140517C71924100 @default.
- W2011140517 hasConceptScore W2011140517C77281830 @default.
- W2011140517 hasConceptScore W2011140517C84393581 @default.
- W2011140517 hasLocation W20111405171 @default.
- W2011140517 hasLocation W20111405172 @default.
- W2011140517 hasOpenAccess W2011140517 @default.
- W2011140517 hasPrimaryLocation W20111405171 @default.
- W2011140517 hasRelatedWork W1983952321 @default.
- W2011140517 hasRelatedWork W1989708172 @default.
- W2011140517 hasRelatedWork W1993163601 @default.
- W2011140517 hasRelatedWork W2058926970 @default.
- W2011140517 hasRelatedWork W2061988168 @default.
- W2011140517 hasRelatedWork W2062121918 @default.
- W2011140517 hasRelatedWork W2073335704 @default.
- W2011140517 hasRelatedWork W2086760877 @default.
- W2011140517 hasRelatedWork W2421990564 @default.
- W2011140517 hasRelatedWork W3210559715 @default.
- W2011140517 hasVolume "421" @default.
- W2011140517 isParatext "false" @default.
- W2011140517 isRetracted "false" @default.
- W2011140517 magId "2011140517" @default.
- W2011140517 workType "article" @default.